Stay updated on Oral Ixazomib Maintenance in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Oral Ixazomib Maintenance in Multiple Myeloma Clinical Trial page.

Latest updates to the Oral Ixazomib Maintenance in Multiple Myeloma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAdded Revision: v3.4.2 and removed older notices about government funding lapse and NIH operating status.SummaryDifference0.6%

- Check20 days agoChange DetectedNotice about government funding status added. Revision label updated from v3.4.0 to v3.4.1.SummaryDifference0.6%

- Check28 days agoChange DetectedShow glossary option, color-coded highlights for changes (green for additions and red for deletions), and a new revision label (v3.4.0) are now displayed on the history page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check42 days agoChange DetectedFooter revision label updated from v3.3.3 to v3.3.4. No changes to study data or core page content.SummaryDifference0.1%

- Check63 days agoChange DetectedFooter updates: added Revision: v3.3.3; HHS Vulnerability Disclosure link and Revision: v3.3.2 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check85 days agoChange DetectedRevision history now includes a new entry for v3.3.2. The previous entry v3.3.1 has been removed from the list.SummaryDifference0.1%

Stay in the know with updates to Oral Ixazomib Maintenance in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Oral Ixazomib Maintenance in Multiple Myeloma Clinical Trial page.